The FDA said there wasn't enough data showing the drugs helped patients and asked for another clinical trial.

The US has denied a bid to allow MDMA, commonly known as ecstasy or molly, to be used in the treatment for post-traumatic stress disorder (PTSD).

The US Food and Drug Administration (FDA) was examining the psychedelic drug made by Lykos Therapeutics to treat the mental health disorder in combination with talk therapy.

    • bobs_monkey@lemm.ee
      2·
      3 months ago

      Exactly. Why have a cheap, one off drug when you can make billions with something expensive that’ll be needed for the duration of your life, and might possibly give you side effects that’ll require additional drugs that they also happen to sell? To not do so would be socialism!